Titre : Mixed function oxygenases

Mixed function oxygenases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Interrupted Time Series Analysis

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une dysfonction des oxydases à fonction mixte ?

Le diagnostic repose sur des tests enzymatiques et l'analyse des métabolites dans le sang.
Oxydases Fonction mixte Dysfonction enzymatique
#2

Quels tests sont utilisés pour évaluer l'activité des oxydases ?

Des tests de métabolisme des médicaments et des analyses biochimiques sont utilisés.
Tests de laboratoire Métabolisme des médicaments Biochimie clinique
#3

Les tests génétiques sont-ils utiles pour ces enzymes ?

Oui, les tests génétiques peuvent identifier des mutations affectant l'activité enzymatique.
Tests génétiques Mutations Enzymopathies
#4

Quels symptômes peuvent indiquer une anomalie enzymatique ?

Des symptômes comme la toxicité médicamenteuse ou des réactions indésirables peuvent survenir.
Toxicité médicamenteuse Réactions indésirables Symptômes cliniques
#5

Comment les antécédents médicaux aident-ils au diagnostic ?

Les antécédents d'exposition à des médicaments ou toxines peuvent orienter le diagnostic.
Antécédents médicaux Exposition aux toxines Évaluation clinique

Symptômes 5

#1

Quels sont les symptômes d'une déficience en oxydases ?

Les symptômes incluent des réactions médicamenteuses imprévues et une toxicité accrue.
Déficience enzymatique Réactions médicamenteuses Toxicité
#2

Peut-on observer des symptômes neurologiques ?

Oui, des symptômes neurologiques peuvent survenir en raison d'une accumulation de toxines.
Symptômes neurologiques Accumulation de toxines Neuropathies
#3

Les symptômes varient-ils selon les individus ?

Oui, la gravité et le type de symptômes peuvent varier selon la génétique et l'environnement.
Variabilité individuelle Génétique Environnement
#4

Quels signes cliniques sont associés à une suractivité enzymatique ?

Une suractivité peut entraîner une dégradation rapide des médicaments et des effets secondaires.
Suractivité enzymatique Effets secondaires Dégradation des médicaments
#5

Les symptômes peuvent-ils être confondus avec d'autres maladies ?

Oui, les symptômes peuvent ressembler à ceux d'autres maladies métaboliques ou hépatiques.
Maladies métaboliques Maladies hépatiques Diagnostic différentiel

Prévention 5

#1

Comment prévenir les dysfonctionnements des oxydases ?

Éviter l'exposition à des médicaments et toxines connus pour affecter ces enzymes.
Prévention Exposition aux toxines Médicaments
#2

L'éducation des patients est-elle importante ?

Oui, informer les patients sur les risques liés aux médicaments est essentiel pour la prévention.
Éducation des patients Risques médicamenteux Prévention des maladies
#3

Les bilans de santé réguliers aident-ils ?

Oui, des bilans réguliers peuvent détecter précocement des anomalies enzymatiques.
Bilan de santé Détection précoce Anomalies enzymatiques
#4

Les habitudes alimentaires influencent-elles la fonction enzymatique ?

Oui, une alimentation équilibrée peut soutenir la santé enzymatique et métabolique.
Habitudes alimentaires Santé métabolique Nutrition
#5

Les vaccinations ont-elles un impact sur la fonction enzymatique ?

Certaines vaccinations peuvent influencer le métabolisme, mais les effets varient.
Vaccinations Métabolisme Effets immunologiques

Traitements 5

#1

Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?

Les traitements incluent des ajustements médicamenteux et des thérapies de soutien.
Traitements médicaux Ajustements médicamenteux Thérapies de soutien
#2

Les suppléments peuvent-ils aider à la fonction enzymatique ?

Oui, certains suppléments peuvent améliorer la fonction enzymatique, selon le cas.
Suppléments nutritionnels Fonction enzymatique Thérapies complémentaires
#3

Comment la pharmacogénétique influence-t-elle le traitement ?

La pharmacogénétique permet de personnaliser les traitements en fonction du profil enzymatique.
Pharmacogénétique Personnalisation des traitements Profil enzymatique
#4

Les traitements sont-ils différents pour les enfants et les adultes ?

Oui, les dosages et les choix de médicaments peuvent varier entre enfants et adultes.
Pédiatrie Dosage médicamenteux Traitements adaptés
#5

Des thérapies géniques sont-elles envisagées ?

Des recherches sont en cours sur les thérapies géniques pour corriger les déficiences enzymatiques.
Thérapie génique Déficiences enzymatiques Recherche biomédicale

Complications 5

#1

Quelles complications peuvent survenir avec une dysfonction enzymatique ?

Des complications incluent des réactions médicamenteuses graves et des maladies hépatiques.
Complications Réactions médicamenteuses Maladies hépatiques
#2

Les complications sont-elles réversibles ?

Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non.
Complications réversibles Traitement Pronostic
#3

Comment les complications affectent-elles la qualité de vie ?

Les complications peuvent réduire la qualité de vie en limitant les options de traitement.
Qualité de vie Complications Options de traitement
#4

Les complications sont-elles plus fréquentes chez certains groupes ?

Oui, certaines populations peuvent être plus à risque en raison de facteurs génétiques.
Groupes à risque Facteurs génétiques Complications
#5

Les complications peuvent-elles être prévenues ?

Certaines complications peuvent être évitées par une surveillance et un traitement précoce.
Prévention des complications Surveillance médicale Traitement précoce

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque pour les dysfonctionnements enzymatiques ?

Les facteurs incluent des antécédents familiaux, l'exposition à des toxines et certains médicaments.
Facteurs de risque Antécédents familiaux Exposition aux toxines
#2

L'âge influence-t-il le risque de dysfonctionnement ?

Oui, le risque peut augmenter avec l'âge en raison de changements métaboliques.
Âge Risque Changements métaboliques
#3

Les maladies chroniques augmentent-elles le risque ?

Oui, certaines maladies chroniques peuvent affecter la fonction enzymatique et augmenter le risque.
Maladies chroniques Fonction enzymatique Risque
#4

Le mode de vie joue-t-il un rôle dans le risque ?

Oui, un mode de vie malsain, comme une mauvaise alimentation, peut augmenter le risque.
Mode de vie Alimentation Risque
#5

Les interactions médicamenteuses sont-elles un facteur de risque ?

Oui, certaines interactions médicamenteuses peuvent altérer l'activité des oxydases à fonction mixte.
Interactions médicamenteuses Risque Oxydases
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mixed function oxygenases : Questions médicales les plus fréquentes", "headline": "Mixed function oxygenases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mixed function oxygenases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-07-08", "dateModified": "2025-04-04", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mixed function oxygenases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Oxygénases", "url": "https://questionsmedicales.fr/mesh/D010105", "about": { "@type": "MedicalCondition", "name": "Oxygénases", "code": { "@type": "MedicalCode", "code": "D010105", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Benzoate 4-monooxygenase", "alternateName": "Benzoate 4-Monooxygenase", "url": "https://questionsmedicales.fr/mesh/D050565", "about": { "@type": "MedicalCondition", "name": "Benzoate 4-monooxygenase", "code": { "@type": "MedicalCode", "code": "D050565", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.062" } } }, { "@type": "MedicalWebPage", "name": "Catechol oxidase", "alternateName": "Catechol Oxidase", "url": "https://questionsmedicales.fr/mesh/D004156", "about": { "@type": "MedicalCondition", "name": "Catechol oxidase", "code": { "@type": "MedicalCode", "code": "D004156", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.125" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Monophenol monooxygenase", "alternateName": "Monophenol Monooxygenase", "url": "https://questionsmedicales.fr/mesh/D014442", "about": { "@type": "MedicalCondition", "name": "Monophenol monooxygenase", "code": { "@type": "MedicalCode", "code": "D014442", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.125.500" } } } ] }, { "@type": "MedicalWebPage", "name": "7-Alkoxycoumarin O-dealkylase", "alternateName": "7-Alkoxycoumarin O-Dealkylase", "url": "https://questionsmedicales.fr/mesh/D015660", "about": { "@type": "MedicalCondition", "name": "7-Alkoxycoumarin O-dealkylase", "code": { "@type": "MedicalCode", "code": "D015660", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.170.010.024" } } }, { "@type": "MedicalWebPage", "name": "Dopamine beta-monooxygenase", "alternateName": "Dopamine beta-Hydroxylase", "url": "https://questionsmedicales.fr/mesh/D004299", "about": { "@type": "MedicalCondition", "name": "Dopamine beta-monooxygenase", "code": { "@type": "MedicalCode", "code": "D004299", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.292" } } }, { "@type": "MedicalWebPage", "name": "Fatty acid desaturases", "alternateName": "Fatty Acid Desaturases", "url": "https://questionsmedicales.fr/mesh/D044943", "about": { "@type": "MedicalCondition", "name": "Fatty acid desaturases", "code": { "@type": "MedicalCode", "code": "D044943", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.392" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "beta-Carotene 15,15'-monooxygenase", "alternateName": "beta-Carotene 15,15'-Monooxygenase", "url": "https://questionsmedicales.fr/mesh/D050559", "about": { "@type": "MedicalCondition", "name": "beta-Carotene 15,15'-monooxygenase", "code": { "@type": "MedicalCode", "code": "D050559", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.392.312" } } }, { "@type": "MedicalWebPage", "name": "Delta-5 fatty acid desaturase", "alternateName": "Delta-5 Fatty Acid Desaturase", "url": "https://questionsmedicales.fr/mesh/D000090943", "about": { "@type": "MedicalCondition", "name": "Delta-5 fatty acid desaturase", "code": { "@type": "MedicalCode", "code": "D000090943", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.392.390" } } }, { "@type": "MedicalWebPage", "name": "Linoleoyl-CoA desaturase", "alternateName": "Linoleoyl-CoA Desaturase", "url": "https://questionsmedicales.fr/mesh/D050602", "about": { "@type": "MedicalCondition", "name": "Linoleoyl-CoA desaturase", "code": { "@type": "MedicalCode", "code": "D050602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.392.468" } } }, { "@type": "MedicalWebPage", "name": "Acyl-(acyl-carrier-protein)desaturase", "alternateName": "Stearoyl-CoA Desaturase", "url": "https://questionsmedicales.fr/mesh/D013230", "about": { "@type": "MedicalCondition", "name": "Acyl-(acyl-carrier-protein)desaturase", "code": { "@type": "MedicalCode", "code": "D013230", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.392.625" } } } ] }, { "@type": "MedicalWebPage", "name": "gamma-butyrobetaine dioxygenase", "alternateName": "gamma-Butyrobetaine Dioxygenase", "url": "https://questionsmedicales.fr/mesh/D050563", "about": { "@type": "MedicalCondition", "name": "gamma-butyrobetaine dioxygenase", "code": { "@type": "MedicalCode", "code": "D050563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.401" } } }, { "@type": "MedicalWebPage", "name": "Heme oxygenase (decyclizing)", "alternateName": "Heme Oxygenase (Decyclizing)", "url": "https://questionsmedicales.fr/mesh/D006419", "about": { "@type": "MedicalCondition", "name": "Heme oxygenase (decyclizing)", "code": { "@type": "MedicalCode", "code": "D006419", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.410" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Heme oxygenase-1", "alternateName": "Heme Oxygenase-1", "url": "https://questionsmedicales.fr/mesh/D051547", "about": { "@type": "MedicalCondition", "name": "Heme oxygenase-1", "code": { "@type": "MedicalCode", "code": "D051547", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.410.500" } } } ] }, { "@type": "MedicalWebPage", "name": "4-Hydroxybenzoate 3-monooxygenase", "alternateName": "4-Hydroxybenzoate-3-Monooxygenase", "url": "https://questionsmedicales.fr/mesh/D015109", "about": { "@type": "MedicalCondition", "name": "4-Hydroxybenzoate 3-monooxygenase", "code": { "@type": "MedicalCode", "code": "D015109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.425" } } }, { "@type": "MedicalWebPage", "name": "Kynurenine 3-monooxygenase", "alternateName": "Kynurenine 3-Monooxygenase", "url": "https://questionsmedicales.fr/mesh/D050601", "about": { "@type": "MedicalCondition", "name": "Kynurenine 3-monooxygenase", "code": { "@type": "MedicalCode", "code": "D050601", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.557" } } }, { "@type": "MedicalWebPage", "name": "Phenylalanine 4-monooxygenase", "alternateName": "Phenylalanine Hydroxylase", "url": "https://questionsmedicales.fr/mesh/D010651", "about": { "@type": "MedicalCondition", "name": "Phenylalanine 4-monooxygenase", "code": { "@type": "MedicalCode", "code": "D010651", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.601" } } }, { "@type": "MedicalWebPage", "name": "Procollagen-lysine, 2-oxoglutarate 5-dioxygenase", "alternateName": "Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase", "url": "https://questionsmedicales.fr/mesh/D008240", "about": { "@type": "MedicalCondition", "name": "Procollagen-lysine, 2-oxoglutarate 5-dioxygenase", "code": { "@type": "MedicalCode", "code": "D008240", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.660" } } }, { "@type": "MedicalWebPage", "name": "Prolyl hydroxylases", "alternateName": "Prolyl Hydroxylases", "url": "https://questionsmedicales.fr/mesh/D064828", "about": { "@type": "MedicalCondition", "name": "Prolyl hydroxylases", "code": { "@type": "MedicalCode", "code": "D064828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.694" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Hypoxia-inducible factor-proline dioxygenases", "alternateName": "Hypoxia-Inducible Factor-Proline Dioxygenases", "url": "https://questionsmedicales.fr/mesh/D064799", "about": { "@type": "MedicalCondition", "name": "Hypoxia-inducible factor-proline dioxygenases", "code": { "@type": "MedicalCode", "code": "D064799", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.694.500" } } }, { "@type": "MedicalWebPage", "name": "Procollagen-Proline Dioxygenase", "alternateName": "Procollagen-Proline Dioxygenase", "url": "https://questionsmedicales.fr/mesh/D011393", "about": { "@type": "MedicalCondition", "name": "Procollagen-Proline Dioxygenase", "code": { "@type": "MedicalCode", "code": "D011393", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.694.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Prostaglandin-endoperoxide synthases", "alternateName": "Prostaglandin-Endoperoxide Synthases", "url": "https://questionsmedicales.fr/mesh/D011451", "about": { "@type": "MedicalCondition", "name": "Prostaglandin-endoperoxide synthases", "code": { "@type": "MedicalCode", "code": "D011451", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.715" } } }, { "@type": "MedicalWebPage", "name": "Squalene monooxygenase", "alternateName": "Squalene Monooxygenase", "url": "https://questionsmedicales.fr/mesh/D050603", "about": { "@type": "MedicalCondition", "name": "Squalene monooxygenase", "code": { "@type": "MedicalCode", "code": "D050603", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.749" } } }, { "@type": "MedicalWebPage", "name": "Trans-cinnamate 4-monooxygenase", "alternateName": "Trans-Cinnamate 4-Monooxygenase", "url": "https://questionsmedicales.fr/mesh/D050564", "about": { "@type": "MedicalCondition", "name": "Trans-cinnamate 4-monooxygenase", "code": { "@type": "MedicalCode", "code": "D050564", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.826" } } }, { "@type": "MedicalWebPage", "name": "Tryptophane 5-monooxygenase", "alternateName": "Tryptophan Hydroxylase", "url": "https://questionsmedicales.fr/mesh/D014365", "about": { "@type": "MedicalCondition", "name": "Tryptophane 5-monooxygenase", "code": { "@type": "MedicalCode", "code": "D014365", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.870" } } }, { "@type": "MedicalWebPage", "name": "Vitamin K epoxide reductases", "alternateName": "Vitamin K Epoxide Reductases", "url": "https://questionsmedicales.fr/mesh/D064417", "about": { "@type": "MedicalCondition", "name": "Vitamin K epoxide reductases", "code": { "@type": "MedicalCode", "code": "D064417", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.682.690.708.961" } } } ], "about": { "@type": "MedicalCondition", "name": "Mixed function oxygenases", "alternateName": "Mixed Function Oxygenases", "code": { "@type": "MedicalCode", "code": "D006899", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Shuyue Wang", "url": "https://questionsmedicales.fr/author/Shuyue%20Wang", "affiliation": { "@type": "Organization", "name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China." } }, { "@type": "Person", "name": "Liang Zhao", "url": "https://questionsmedicales.fr/author/Liang%20Zhao", "affiliation": { "@type": "Organization", "name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China." } }, { "@type": "Person", "name": "Tingting Li", "url": "https://questionsmedicales.fr/author/Tingting%20Li", "affiliation": { "@type": "Organization", "name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China." } }, { "@type": "Person", "name": "Huizhen Wang", "url": "https://questionsmedicales.fr/author/Huizhen%20Wang", "affiliation": { "@type": "Organization", "name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China." } }, { "@type": "Person", "name": "Zhenmin Bao", "url": "https://questionsmedicales.fr/author/Zhenmin%20Bao", "affiliation": { "@type": "Organization", "name": "MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Universal HIV screening in the emergency department: an interrupted time series analysis.", "datePublished": "2022-06-22", "url": "https://questionsmedicales.fr/article/35730396", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/QAD.0000000000003282" } }, { "@type": "ScholarlyArticle", "name": "Trauma team leader and early mortality: An interrupted time series analysis.", "datePublished": "2022-10-07", "url": "https://questionsmedicales.fr/article/36244124", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ajem.2022.09.048" } }, { "@type": "ScholarlyArticle", "name": "Suicide among soldiers and social contagion effects: An interrupted time-series analysis.", "datePublished": "2023-02-03", "url": "https://questionsmedicales.fr/article/36746079", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.socscimed.2023.115747" } }, { "@type": "ScholarlyArticle", "name": "Effects of the economic recession on suicide mortality in Brazil: interrupted time series analysis.", "datePublished": "2022-06-10", "url": "https://questionsmedicales.fr/article/35703676", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1590/0034-7167-2021-0778" } }, { "@type": "ScholarlyArticle", "name": "Health worker protests and the COVID-19 pandemic: an interrupted time-series analysis.", "datePublished": "2024-07-04", "url": "https://questionsmedicales.fr/article/39219771", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2471/BLT.23.290330" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Oxidoreductases", "item": "https://questionsmedicales.fr/mesh/D010088" }, { "@type": "ListItem", "position": 5, "name": "Oxygénases", "item": "https://questionsmedicales.fr/mesh/D010105" }, { "@type": "ListItem", "position": 6, "name": "Mixed function oxygenases", "item": "https://questionsmedicales.fr/mesh/D006899" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mixed function oxygenases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mixed function oxygenases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mixed function oxygenases", "description": "Comment diagnostiquer une dysfonction des oxydases à fonction mixte ?\nQuels tests sont utilisés pour évaluer l'activité des oxydases ?\nLes tests génétiques sont-ils utiles pour ces enzymes ?\nQuels symptômes peuvent indiquer une anomalie enzymatique ?\nComment les antécédents médicaux aident-ils au diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Interrupted+Time+Series+Analysis#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mixed function oxygenases", "description": "Quels sont les symptômes d'une déficience en oxydases ?\nPeut-on observer des symptômes neurologiques ?\nLes symptômes varient-ils selon les individus ?\nQuels signes cliniques sont associés à une suractivité enzymatique ?\nLes symptômes peuvent-ils être confondus avec d'autres maladies ?", "url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Interrupted+Time+Series+Analysis#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mixed function oxygenases", "description": "Comment prévenir les dysfonctionnements des oxydases ?\nL'éducation des patients est-elle importante ?\nLes bilans de santé réguliers aident-ils ?\nLes habitudes alimentaires influencent-elles la fonction enzymatique ?\nLes vaccinations ont-elles un impact sur la fonction enzymatique ?", "url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Interrupted+Time+Series+Analysis#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mixed function oxygenases", "description": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?\nLes suppléments peuvent-ils aider à la fonction enzymatique ?\nComment la pharmacogénétique influence-t-elle le traitement ?\nLes traitements sont-ils différents pour les enfants et les adultes ?\nDes thérapies géniques sont-elles envisagées ?", "url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Interrupted+Time+Series+Analysis#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mixed function oxygenases", "description": "Quelles complications peuvent survenir avec une dysfonction enzymatique ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nLes complications sont-elles plus fréquentes chez certains groupes ?\nLes complications peuvent-elles être prévenues ?", "url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Interrupted+Time+Series+Analysis#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mixed function oxygenases", "description": "Quels sont les principaux facteurs de risque pour les dysfonctionnements enzymatiques ?\nL'âge influence-t-il le risque de dysfonctionnement ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie joue-t-il un rôle dans le risque ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D006899?mesh_terms=Interrupted+Time+Series+Analysis#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une dysfonction des oxydases à fonction mixte ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests enzymatiques et l'analyse des métabolites dans le sang." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'activité des oxydases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de métabolisme des médicaments et des analyses biochimiques sont utilisés." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour ces enzymes ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier des mutations affectant l'activité enzymatique." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer une anomalie enzymatique ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la toxicité médicamenteuse ou des réactions indésirables peuvent survenir." } }, { "@type": "Question", "name": "Comment les antécédents médicaux aident-ils au diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'exposition à des médicaments ou toxines peuvent orienter le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en oxydases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des réactions médicamenteuses imprévues et une toxicité accrue." } }, { "@type": "Question", "name": "Peut-on observer des symptômes neurologiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes neurologiques peuvent survenir en raison d'une accumulation de toxines." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon les individus ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité et le type de symptômes peuvent varier selon la génétique et l'environnement." } }, { "@type": "Question", "name": "Quels signes cliniques sont associés à une suractivité enzymatique ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une suractivité peut entraîner une dégradation rapide des médicaments et des effets secondaires." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils être confondus avec d'autres maladies ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent ressembler à ceux d'autres maladies métaboliques ou hépatiques." } }, { "@type": "Question", "name": "Comment prévenir les dysfonctionnements des oxydases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des médicaments et toxines connus pour affecter ces enzymes." } }, { "@type": "Question", "name": "L'éducation des patients est-elle importante ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, informer les patients sur les risques liés aux médicaments est essentiel pour la prévention." } }, { "@type": "Question", "name": "Les bilans de santé réguliers aident-ils ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des bilans réguliers peuvent détecter précocement des anomalies enzymatiques." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles la fonction enzymatique ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut soutenir la santé enzymatique et métabolique." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un impact sur la fonction enzymatique ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent influencer le métabolisme, mais les effets varient." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour les dysfonctionnements enzymatiques ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des ajustements médicamenteux et des thérapies de soutien." } }, { "@type": "Question", "name": "Les suppléments peuvent-ils aider à la fonction enzymatique ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains suppléments peuvent améliorer la fonction enzymatique, selon le cas." } }, { "@type": "Question", "name": "Comment la pharmacogénétique influence-t-elle le traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La pharmacogénétique permet de personnaliser les traitements en fonction du profil enzymatique." } }, { "@type": "Question", "name": "Les traitements sont-ils différents pour les enfants et les adultes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les dosages et les choix de médicaments peuvent varier entre enfants et adultes." } }, { "@type": "Question", "name": "Des thérapies géniques sont-elles envisagées ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des recherches sont en cours sur les thérapies géniques pour corriger les déficiences enzymatiques." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une dysfonction enzymatique ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications incluent des réactions médicamenteuses graves et des maladies hépatiques." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles avec un traitement approprié, d'autres non." } }, { "@type": "Question", "name": "Comment les complications affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent réduire la qualité de vie en limitant les options de traitement." } }, { "@type": "Question", "name": "Les complications sont-elles plus fréquentes chez certains groupes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines populations peuvent être plus à risque en raison de facteurs génétiques." } }, { "@type": "Question", "name": "Les complications peuvent-elles être prévenues ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par une surveillance et un traitement précoce." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour les dysfonctionnements enzymatiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, l'exposition à des toxines et certains médicaments." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de dysfonctionnement ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le risque peut augmenter avec l'âge en raison de changements métaboliques." } }, { "@type": "Question", "name": "Les maladies chroniques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies chroniques peuvent affecter la fonction enzymatique et augmenter le risque." } }, { "@type": "Question", "name": "Le mode de vie joue-t-il un rôle dans le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie malsain, comme une mauvaise alimentation, peut augmenter le risque." } }, { "@type": "Question", "name": "Les interactions médicamenteuses sont-elles un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines interactions médicamenteuses peuvent altérer l'activité des oxydases à fonction mixte." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 04/04/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

25 au total
└─

Benzoate 4-monooxygenase

Benzoate 4-Monooxygenase D050565 - D08.811.682.690.708.062
└─

Catechol oxidase

Catechol Oxidase D004156 - D08.811.682.690.708.125
└─

Dopamine beta-monooxygenase

Dopamine beta-Hydroxylase D004299 - D08.811.682.690.708.292
└─

Fatty acid desaturases

Fatty Acid Desaturases D044943 - D08.811.682.690.708.392
└─

gamma-butyrobetaine dioxygenase

gamma-Butyrobetaine Dioxygenase D050563 - D08.811.682.690.708.401
└─

Heme oxygenase (decyclizing)

Heme Oxygenase (Decyclizing) D006419 - D08.811.682.690.708.410
└─

4-Hydroxybenzoate 3-monooxygenase

4-Hydroxybenzoate-3-Monooxygenase D015109 - D08.811.682.690.708.425
└─

Kynurenine 3-monooxygenase

Kynurenine 3-Monooxygenase D050601 - D08.811.682.690.708.557
└─

Phenylalanine 4-monooxygenase

Phenylalanine Hydroxylase D010651 - D08.811.682.690.708.601
└─

Procollagen-lysine, 2-oxoglutarate 5-dioxygenase

Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase D008240 - D08.811.682.690.708.660
└─

Prolyl hydroxylases

Prolyl Hydroxylases D064828 - D08.811.682.690.708.694
└─

Prostaglandin-endoperoxide synthases

Prostaglandin-Endoperoxide Synthases D011451 - D08.811.682.690.708.715
└─

Squalene monooxygenase

Squalene Monooxygenase D050603 - D08.811.682.690.708.749
└─

Trans-cinnamate 4-monooxygenase

Trans-Cinnamate 4-Monooxygenase D050564 - D08.811.682.690.708.826
└─

Tryptophane 5-monooxygenase

Tryptophan Hydroxylase D014365 - D08.811.682.690.708.870
└─

Vitamin K epoxide reductases

Vitamin K Epoxide Reductases D064417 - D08.811.682.690.708.961
└─└─

Monophenol monooxygenase

Monophenol Monooxygenase D014442 - D08.811.682.690.708.125.500
└─└─

beta-Carotene 15,15'-monooxygenase

beta-Carotene 15,15'-Monooxygenase D050559 - D08.811.682.690.708.392.312
└─└─

Delta-5 fatty acid desaturase

Delta-5 Fatty Acid Desaturase D000090943 - D08.811.682.690.708.392.390
└─└─

Linoleoyl-CoA desaturase

Linoleoyl-CoA Desaturase D050602 - D08.811.682.690.708.392.468
└─└─

Acyl-(acyl-carrier-protein)desaturase

Stearoyl-CoA Desaturase D013230 - D08.811.682.690.708.392.625
└─└─

Heme oxygenase-1

Heme Oxygenase-1 D051547 - D08.811.682.690.708.410.500
└─└─

Hypoxia-inducible factor-proline dioxygenases

Hypoxia-Inducible Factor-Proline Dioxygenases D064799 - D08.811.682.690.708.694.500
└─└─

Procollagen-Proline Dioxygenase

Procollagen-Proline Dioxygenase D011393 - D08.811.682.690.708.694.750
└─└─└─

7-Alkoxycoumarin O-dealkylase

7-Alkoxycoumarin O-Dealkylase D015660 - D08.811.682.690.708.170.010.024

Auteurs principaux

Shuyue Wang

2 publications dans cette catégorie

Affiliations :
  • MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.
Publications dans "Mixed function oxygenases" :

Liang Zhao

2 publications dans cette catégorie

Affiliations :
  • MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.
Publications dans "Mixed function oxygenases" :

Tingting Li

2 publications dans cette catégorie

Affiliations :
  • MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.
Publications dans "Mixed function oxygenases" :

Huizhen Wang

2 publications dans cette catégorie

Affiliations :
  • MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.
  • Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266237, China.
Publications dans "Mixed function oxygenases" :

Zhenmin Bao

2 publications dans cette catégorie

Affiliations :
  • MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.
  • Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266237, China.
  • Laboratory of Tropical Marine Germplasm Resources and Breeding Engineering, Sanya Oceanographic Institution, Ocean University of China, Sanya 572000, China.
Publications dans "Mixed function oxygenases" :

Xiaoli Hu

2 publications dans cette catégorie

Affiliations :
  • MOE Key Laboratory of Molecular Genetics and Breeding, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, China.
  • Laboratory for Marine Fisheries Science and Food Production Processes, Qingdao National Laboratory for Marine Science and Technology, Qingdao 266237, China.
Publications dans "Mixed function oxygenases" :

Jianxin Liu

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
Publications dans "Mixed function oxygenases" :

Madison Knapp

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
Publications dans "Mixed function oxygenases" :

Jennifer Bridwell-Rabb

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
Publications dans "Mixed function oxygenases" :

Jian-Bo Yu

2 publications dans cette catégorie

Affiliations :
  • Department of Anesthesiology and Critical Care Medicine, Tianjin Nankai Hospital, Tianjin Medical University, Tianjin, P.R. China. Electronic address: 30717008@nankai.edu.cn.

Fan Yang

2 publications dans cette catégorie

Affiliations :
  • CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Microbial Resources, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
  • University of the Chinese Academy of Sciences, Beijing, China.
  • CAS Key Laboratory of Microbial Physiological and Metabolic Engineering, State Key Laboratory of Transducer Technology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, 100101, China.
Publications dans "Mixed function oxygenases" :

Ikuro Abe

2 publications dans cette catégorie

Affiliations :
  • Graduate School of Pharmaceutical Sciences, The University of Tokyo, Tokyo, Japan; Collaborative Research Institute for Innovative Microbiology, The University of Tokyo, Tokyo, Japan. Electronic address: abei@mol.f.u-tokyo.ac.jp.
Publications dans "Mixed function oxygenases" :

Heng Guo

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence on Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China. wliu@mail.sioc.ac.cn.
Publications dans "Mixed function oxygenases" :

Xuebing Bai

2 publications dans cette catégorie

Affiliations :
  • Department of General Dentistry, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, 639 Zhizaoju Road, Shanghai 200011, China. taojiang_doctor@hotmail.com.
Publications dans "Mixed function oxygenases" :

Qian Yang

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence on Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China. wliu@mail.sioc.ac.cn.
Publications dans "Mixed function oxygenases" :

Yufeng Xue

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence on Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China. wliu@mail.sioc.ac.cn.
Publications dans "Mixed function oxygenases" :

Dandan Chen

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence on Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China. wliu@mail.sioc.ac.cn.
  • Huzhou Center of Bio-Synthetic Innovation, 1366 Hongfeng Road, Huzhou 313000, China. ddchen@sioc.ac.cn.
Publications dans "Mixed function oxygenases" :

Jiang Tao

2 publications dans cette catégorie

Affiliations :
  • Department of General Dentistry, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine; National Clinical Research Center for Oral Diseases; Shanghai Key Laboratory of Stomatology & Shanghai Research Institute of Stomatology, 639 Zhizaoju Road, Shanghai 200011, China. taojiang_doctor@hotmail.com.
Publications dans "Mixed function oxygenases" :

Wen Liu

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence on Molecular Synthesis, Shanghai Institute of Organic Chemistry, University of Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China. wliu@mail.sioc.ac.cn.
  • Huzhou Center of Bio-Synthetic Innovation, 1366 Hongfeng Road, Huzhou 313000, China. ddchen@sioc.ac.cn.
Publications dans "Mixed function oxygenases" :

Reiko Akagi

2 publications dans cette catégorie

Affiliations :
  • Department of Pharmacy, Faculty of Pharmacy, Yasuda Women's University, 6-13-1 Yasuhigashi, Asaminami-ku, Hiroshima 731-0153, Japan.

Sources (10000 au total)

Trauma team leader and early mortality: An interrupted time series analysis.

The trauma team leader (TTL) is a "model" of a specifically dedicated team leader in the emergency department (ED), but its benefits are uncertain. The primary objective was to assess the impact of th... Major trauma admissions (Injury Severity Score (ISS)≥12) in 3 Canadian Level-1 trauma centres were included from 2003 to 2017. The TTL program was implemented in centre 1 in 2005. An interrupted time ... TTL implementation was not associated with changes in mortality or admission delays from the ED. Future studies should assess the potential impact of TTL programs on other patient-centred outcomes usi...

Suicide among soldiers and social contagion effects: An interrupted time-series analysis.

Suicide has become an increasingly concerning problem among soldiers in recent years. Previous research has hypothesized that media-related social contagion effects, termed "Werther effects," may cont... An interrupted time-series analysis, relying on annual military suicide rates between 1873 and 1910, indicated a significant increase in the suicide rate the year of Rudolf's death, a pattern consiste... Although we are very careful when interpreting causal effects with our historical data, we discuss the latter finding by questioning whether a change in military culture, that is, the establishment of...

Effects of the economic recession on suicide mortality in Brazil: interrupted time series analysis.

to analyze trends in suicide rates in Brazil in the period before and after the start of the economic recession.... interrupted time series research using national suicide data recorded in the period between 2012 and 2017 with socioeconomic subgroups analyses. Quasi-Poisson regression model was employed to analyze ... there was an abrupt increase in the risk of suicide after economic recession in the population with less education (12.5%; RR = 1.125; 95%CI: 1.027; 1.232) and in the South Region (17.7%; 1.044; 1.328... the Brazilian economic recession caused different effects on suicide rates, considering social strata, which requires health strategies and policies that are sensitive to the most vulnerable populatio...

Health worker protests and the COVID-19 pandemic: an interrupted time-series analysis.

To assess the impact of the coronavirus disease 2019 (COVID-19) pandemic on protests by health workers.... We conducted an interrupted time series analysis of data from 159 countries for 2 years before and after the World Health Organization classified COVID-19 as a pandemic in March 2020, thus between 201... In total, there were 18 322 health worker protests in 133 countries between 2018 and 2022. The number of weekly health worker protests globally increased by 47% (30.1/63.5), an increase of 30.1 protes... The pandemic increased the overall level of health worker protests globally as well as the number of countries experiencing such protests. These protests highlight discontent in the health workforce. ...

Impact of a prenatal screening program on the Down syndrome phenotype: An interrupted time series analysis.

We hypothesized that children with Down syndrome who were born after the implementation of first-trimester combined screening for trisomy 13, 18, and 21 and a second-trimester ultrasound scan in Denma... A nationwide register-based study of all live born singletons with Down syndrome in Denmark from 1995 to 2018. In interrupted time series analyses, we studied the temporal developments in birth biomet... We included 602 singletons with Down syndrome born before and 308 after implementation of the screening program. Z-scores of birthweight and head circumference increased over time before screening, bu... After implementation of a national prenatal screening program, we did not observe a milder Down syndrome phenotype apart from an apparent reduction in the proportion of children with non-severe congen...

Publicly subsidised smoking cessation medicines in times of COVID-19 in Australia: An interrupted time series analysis.

In Australia, the available published literature demonstrated a spike in dispensed prescription medicines after the onset of the COVID-19 pandemic that subsequently returned to expected levels. Smokin... Australia's universal health-care system provides access to government-subsidised medicines via the Pharmaceutical Benefits Scheme and records of dispensed medicines are publicly available on a nation... After an initial spike in medicines at the onset of the pandemic, the monthly rate of prescriptions dispensed for varenicline was predominantly within predicted ranges, while that of NRT patches was p... There has been a differential change in the number of subsidised smoking cessation medicines supplied in Australia since the COVID-19 pandemic, with varenicline prescriptions largely within, and NRT p...

Seasonality of the incidence of bronchiolitis in infants - Brazil, 2016-2022: An interrupted time-series analysis.

To evaluate the seasonality of acute bronchiolitis in Brazil during the 2020-2022 season and compare it with the previous seasons.... Data from the incidence of hospitalizations due to acute bronchiolitis in infants <1 year of age were obtained from the Department of Informatics of the Brazilian Public Health database for the period... Compared to the pre-COVID-19 period, the incidence of hospitalizations related to acute bronchiolitis decreased by 97% during non-pharmacological interventions (March 2020 - August 2021) but increased... This study underscores the significant influence of COVID-19 interventions on acute bronchiolitis hospitalizations in Brazil. The restoration of a seasonal pattern in 2022 highlights the interplay bet...